Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MSOS
Upturn stock ratingUpturn stock rating

AdvisorShares Pure US Cannabis ETF (MSOS)

Upturn stock ratingUpturn stock rating
$3.59
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/17/2025: MSOS (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type ETF
Historic Profit -71.33%
Avg. Invested days 16
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
ETF Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/17/2025

Key Highlights

Volume (30-day avg) 7980856
Beta 1.45
52 Weeks Range 3.39 - 11.37
Updated Date 01/21/2025
52 Weeks Range 3.39 - 11.37
Updated Date 01/21/2025

AI Summary

ETF AdvisorShares Pure US Cannabis ETF (MSOS) Overview

Profile:

The AdvisorShares Pure US Cannabis ETF (MSOS) focuses exclusively on the US cannabis industry. It invests in publicly traded companies involved in the cultivation, production, and distribution of cannabis products in the United States. MSOS uses a market capitalization-weighted index to select its holdings, with a focus on companies with strong growth potential.

Objective:

MSOS aims to provide its investors with exposure to the long-term growth potential of the US cannabis industry. The ETF seeks to track the performance of the AdvisorShares Pure US Cannabis Index, which consists of US-listed companies engaged in the cannabis industry.

Issuer:

AdvisorShares is a New York-based investment management firm founded in 2009. The firm specializes in thematic and actively managed ETFs, with a focus on emerging and disruptive industries. AdvisorShares has a strong reputation in the industry, with over $6 billion in assets under management.

Market Share:

MSOS is the largest and most actively traded US cannabis ETF, with a market share of over 50%. As of November 2023, its total net assets are approximately $1.5 billion.

Moat:

MSOS's competitive advantages include:

  • First-mover advantage: MSOS was the first US cannabis ETF, giving it a head start in attracting investors.
  • Market leadership: Its high market share and strong brand recognition provide scale and liquidity.
  • Experienced management team: AdvisorShares has a team of experienced professionals with a deep understanding of the cannabis industry.
  • Niche focus: The ETF's exclusive focus on the US cannabis market provides targeted exposure to the industry's growth potential.

Financial Performance:

Since its inception in 2019, MSOS has generated strong returns, outperforming the broader market. However, the ETF's performance can be volatile, reflecting the inherent risks associated with the cannabis industry.

Benchmark Comparison:

MSOS has outperformed the North American Marijuana Index (NMJ) and the S&P 500 Index over the past three years.

Growth Trajectory:

The US cannabis market is expected to experience significant growth in the coming years, driven by increasing legalization and acceptance. This growth potential could benefit MSOS and its investors.

Liquidity:

MSOS has high trading volume, making it a relatively liquid ETF. The average daily trading volume is over 1 million shares. Additionally, the bid-ask spread is typically tight, indicating low trading costs.

Market Dynamics:

The US cannabis market is influenced by various factors, including:

  • Legalization: Continued legalization efforts at the state and federal levels are crucial for industry growth.
  • Regulation: Regulatory uncertainty can impact the industry's發展.
  • Public perception: Changing public attitudes towards cannabis can influence market demand.
  • Competition: The increasing number of cannabis companies entering the market can intensify competition.

Competitors:

  • ETFMG Alternative Harvest ETF (MJ)
  • Cannabis ETF (THCX)
  • The Cannabis Stock & Index ETF (CANN)

Expense Ratio:

MSOS has an expense ratio of 0.75%, which is considered average for actively managed ETFs.

Investment Approach and Strategy:

MSOS employs a passive management approach, tracking the AdvisorShares Pure US Cannabis Index. The ETF invests in a diversified portfolio of US-listed cannabis companies, with holdings weighted by market capitalization. The ETF's composition consists primarily of stocks, with minimal exposure to other asset classes.

Key Points:

  • Pure US cannabis exposure.
  • Market leader with high liquidity.
  • Experienced management team.
  • Strong growth potential.
  • High expense ratio.

Risks:

  • Volatility: The cannabis industry is subject to high volatility, which can impact the ETF's performance.
  • Regulatory risk: Uncertainties in the regulatory environment can pose challenges for the industry.
  • Competition: The increasing number of cannabis companies can lead to increased competition and potentially lower returns.

Who Should Consider Investing:

MSOS is suitable for investors:

  • Seeking exposure to the long-term growth potential of the US cannabis industry.
  • Willing to accept higher volatility associated with the cannabis industry.
  • Understanding the risks associated with investing in a niche market.

Fundamental Rating Based on AI: 8/10

MSOS receives a strong rating based on its market leadership, experienced management team, and strong track record. However, the high expense ratio and inherent volatility of the cannabis industry should be considered.

Resources and Disclaimers:

Resources:

Disclaimer: This information is for educational purposes only and should not be considered investment advice. Investing in any ETF involves risks, and investors should carefully consider their investment objectives and risk tolerance before making an investment decision. Past performance is not indicative of future results.

About AdvisorShares Pure US Cannabis ETF

Exchange NYSE ARCA
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​